Stem cells restore mouse brains after stroke — step toward cerebral regeneration
Scientists from Zurich have made an impressive discovery: after a stroke, they transplanted neuronal stem cells into damaged brain areas of mice. These cells not only survived but integrated into existing neural circuits. Within five weeks, the new cells showed signs of axon growth, vascular regeneration, reduced inflammation, and even partial recovery of motor functions.
Stroke remains one of the leading causes of disability: about one in four adults will experience it in their lifetime, often with severe consequences. Currently, no therapy can reverse neuronal damage. But the Swiss team’s results are striking: they used human neuronal stem cells derived from induced pluripotent cells and injected them into the mice’s brains one week after stroke — not immediately, but in a window potentially applicable to humans.
Unexpectedly, the transplanted cells not only survived but developed: they became neurons, connected with native cells, stimulated neovascularization, and improved the integration of affected brain areas. Signs of blood-brain barrier restoration and reduced inflammation were also observed. Importantly, the motor symptoms of stroke in mice improved, confirmed even by AI-based gait analysis.
Remarkably, the best recovery occurred not with immediate transplantation but one week after the stroke — providing a valuable time frame for medical interventions in humans. The Zurich team is already developing animal-free cell production protocols and safety technologies to avoid uncontrolled growth.
If these approaches can be adapted to clinical conditions, stroke may cease to be an irreversible sentence. We may be on the verge of an era where neuron loss is not the end, but a temporary obstacle that biotechnology can overcome.
